NCT07343297

Brief Summary

The overall goal of this study is to assess the implementation of the Ask Questions about Clinical Trials (ASQ-CT) brochure, a patient-focused communication tool previously demonstrated to improve patient-provider communication about clinical trials. Participants will be given the ASQ-CT brochure at Time 1 (baseline) and participants will complete a questionnaire at three timepoints, baseline (Time 1), Pre-Research Visit (Time 2), and Post-Research Visit (Time 3).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
293

participants targeted

Target at P75+ for not_applicable

Timeline
15mo left

Started Dec 2026

Geographic Reach
1 country

8 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 15, 2026

Completed
12 months until next milestone

Study Start

First participant enrolled

December 30, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2027

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2028

Last Updated

August 6, 2026

Status Verified

June 1, 2026

Enrollment Period

1 year

First QC Date

December 15, 2025

Last Update Submit

August 4, 2026

Conditions

OncologyCardiac DiseaseNeurologic Disorder

Outcome Measures

Primary Outcomes (1)

  • Effectiveness - Self-Efficacy in managing patient-provider interactions - Quantitative Scale

    Improvement of self-efficacy in managing patient-providers interactions between baseline (Time 1) and pre-clinic visit (Time 2). Measured using scale of 1-5 where a higher score is equal to a better outcome

    From Baseline (Time 1) to end of Pre-Clinic Visit (Time 2)

Secondary Outcomes (10)

  • Reach - Number and Proportion

    At start of Participation

  • Effectiveness - Self-Efficacy in managing patient-provider interactions - Quantitative Scale

    From Pre-Clinic (Time 2) to end of Post-Clinic Visit (Time 3) up to 3 months.

  • Effectiveness - Knowledge - Quantitative Scale

    From Baseline (Time 1) to end of Pre-Clinic Visit (Time 2)

  • Effectiveness - Knowledge - Quantitative Scale

    From Pre-Clinic Visit (Time 2) to end of Post-Clinic Visit (Time 3) up to 3 months

  • Effectiveness - Trust - Quantitative Scale

    From Baseline (Time 1) to end of Pre-Clinic Visit (Time 2)

  • +5 more secondary outcomes

Study Arms (1)

Ask Questions about Clinical Trials (ASQ-CT) Brochure

EXPERIMENTAL

Ask Questions about Clinical Trials (ASQ-CT), a clinical trial communication intervention brochure

Behavioral: Ask Questions about Clinical Trials brochure

Interventions

Ask Questions about Clinical Trials brochureBEHAVIORAL

Communication intervention called a question prompt list

Ask Questions about Clinical Trials (ASQ-CT) Brochure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> or equal to 18 years
  • Appointment to see a provider at a Karmanos Cancer Institute-McLaren or a medical encounter at McLaren Center for Research and Innovation (MCRI) site for medical/systemic treatment
  • Potentially eligible for a clinical trial
  • Speak and read English well enough to be able to understand consent documents and complete surveys

You may not qualify if:

  • Not able to complete study documents on their own physically or cognitively

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

Karmanos Cancer Institute at McLaren Bay Region

Bay City, Michigan, 48706, United States

RECRUITING

Karmanos Cancer Institute at McLaren Clarkston

Clarkston, Michigan, 48346, United States

RECRUITING

Karmanos Cancer Institute at McLaren Greater Lansing

Lansing, Michigan, 48910, United States

RECRUITING

Karmanos Cancer Institute at McLaren Lapeer

Lapeer, Michigan, 48446, United States

RECRUITING

Karmanos Cancer Institute at McLaren Macomb

Mount Clemens, Michigan, 48043, United States

RECRUITING

Karmanos Cancer Institute at McLaren Central Michigan, Morey Cancer Center

Mount Pleasant, Michigan, 48858, United States

RECRUITING

Karmanos Cancer Institute at McLaren Northern Michigan

Petoskey, Michigan, 49770, United States

RECRUITING

Karmanos Cancer Institute at McLaren Port Huron

Port Huron, Michigan, 48060, United States

RECRUITING

MeSH Terms

Conditions

NeoplasmsHeart DiseasesNervous System Diseases

Condition Hierarchy (Ancestors)

Cardiovascular Diseases

Study Officials

  • Lauren M Hamel, PhD, MBA

    Wayne State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lauren M Hamel, PhD, MBA

CONTACT

1-800-527-6266Lauren.Hamel@med.wayne.edu

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 15, 2025

First Posted

January 15, 2026

Study Start (Estimated)

December 30, 2026

Primary Completion (Estimated)

December 30, 2027

Study Completion (Estimated)

April 5, 2028

Last Updated

August 6, 2026

Record last verified: 2026-06

Locations

US(8)